Is it effective to take only venetoclax/venetoclax for chemotherapy?
Venetoclax/Venetoclax is a targeted drug for B-cell lymphoma and certain types of leukemia. It induces cancer cell apoptosis by selectively inhibiting BCL-2 protein. It is mainly used to treat chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). Regarding the effectiveness of venetoclax alone without chemotherapy, studies have shown some efficacy in certain patient groups, but there are several factors to consider.
The efficacy of venetoclax is closely related to the patient's specific condition. In some patients with chronic lymphocytic leukemia, venetoclax can effectively reduce tumor burden and improve patient survival, especially those who do not respond to other traditional treatments. Clinical trials have shown that venetoclax is more effective when used in combination with other drugs. When used alone, although some patients will have a good response, the overall effect may not be as good as the combination therapy.
Long-term use of a certain targeted drug may cause cancer cells to gradually adapt and develop drug resistance, thus affecting the effectiveness of treatment. Therefore, some doctors will recommend combining venetoclax with other treatments to enhance the efficacy and delay the emergence of drug resistance, such as Rituximab, Otuzumab, Azacitidine, Decitabine or low-dose Cytarabine. In addition, the use of venetoclax requires monitoring of patients' hematological parameters to ensure that no serious side effects or complications occur, especially during the initial treatment phase.
The use of venetoclax also requires consideration of the patient's quality of life. Targeted therapies often have fewer side effects than traditional chemotherapy, and patients may be able to maintain a better quality of life while receiving treatment. However, for some patients, using venetoclax alone may not be able to achieve cure, so you should fully communicate with your doctor during the treatment process to formulate a reasonable treatment plan.
Reference materials:https://www.venclexta.com/previously-untreated-cll/why-venclexta/how-it-works
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)